Catherine Hatton

@DiMeN_DTP PhD student at Newcastle University studying viral encephalitis

[Catherine Hatton @CatherineHatton]

Learnt so much at the @EBItraining scRNA-seq analysis course last week! #Bioinformatics #R

[EMBL-EBI Training @EBItraining]

👏A fabulous week of virtual learning on the analysis of scRNA-seq data using R and command line tools. Thank you to all the trainers, organisers, and participants!

🔎Looking for more #scRNA training? Apply now for our @galaxyproject focussed course: https://t.co/uzkJLWp7Bv

[Lauren Beck @_LaurenBeck]

Super happy to share our new paper which has just been published!! A study looking at the impact of probiotics on the healthy preterm gut microbiome https://t.co/65ovnRKJ6t huuuuge thanks to everyone involved…please check it out 😌😇

[Catherine Hatton @CatherineHatton]

On my way to #CSNeuroImmune22 for my first in-person international conference 👩‍🔬🇵🇹

[Catherine Hatton @CatherineHatton]

So happy to talk at the @bsicongress immunology north east event today! #firstplace #presentation #zikavirus 👩‍🔬🧫🦠

[Rockefeller U. Press @RockUPress]

A new form of inherited IFNAR2 deficiency associated with severe outcomes of viral disease, reported in @JExpMed by @chrisjaduncan @KelderMorten Sophie Hambleton, Trine Mogensen, @A_Albrechtsen @CatherineHatton & colleagues @UniofNewcastle @AarhusUni_int: https://t.co/hiUkKooQLD

[bioRxiv @biorxivpreprint]

Type I interferons govern Zika virus resistance of human macrophages and microglia https://t.co/QkxSTUo6Ft #bioRxiv

[Christopher J A Duncan @chrisjaduncan]

New work from our lab and awesome collaborators out today in @NatureComms. We used #scRNAsequencing and #proteomics to investigate responses to SARS-CoV-2 in nasal cells, a major portal of entry.

https://t.co/0p5VTrvUWS

Fantastic team @UniofNewcastle (see 🧵below)

[Catherine Hatton @CatherineHatton]

Excited to be presenting our labs SARS-CoV-2 work at the #UKCICconference today! 🦠👩‍🔬
@UKCICstudy

Delayed induction of type I and III interferons and nasal epithelial cell permissiveness to SARS-CoV-2 https://t.co/TwRnUNYiIB

[bioRxiv @biorxivpreprint]

Delayed induction of type I and III interferons and nasal epithelial cell permissiveness to SARS-CoV-2 https://t.co/xsMzIbRE6U #bioRxiv

[Prof. Akiko Iwasaki @VirusesImmunity]

Are you confused about the role of type I interferons (IFN) in #SARS_CoV_2 infection?

Here is my speculation on what makes IFN-I helpful vs. harmful in #COVID19 patients - it comes down to timing and dose. A short thread.

All figures made by @BioRender & @annsea_park (1/n)

[Andrea Chiara Masi @ACMasi10]

Really excited to present some of my research at the @NEPGconference this year! I’ll be talking about human milk oligosaccharides, preterm gut microbiome, and their association with Necrotising enterocolitis.

[DiMeN DTP @DiMeN_DTP]

Congratulations to new DiMeN student Catherine Hatton for publishing her first paper:
"Microglia Are Essential to Protective Antiviral Immunity: Lessons From Mouse Models of Viral Encephalitis" in Frontiers in Immunology.

https://t.co/JjLvXvyw6x